Maraviroc Tablet, Film Coated
Product Images NDC 72319-025

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 72319-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-structure (Chem Structure.jpg)

Chemical structure of Maraviroc, depicting the arrangement of its atoms and bonds, including fluorinated cyclohexane, phenyl, and azabicyclo motifs, along with triazole and methyl groups.*

FDA Label Image

Maraviroc-150mg (Maraviroc 150mg.jpg)

Maraviroc Tablets 150 mg film-coated tablets label displaying NDC 72319-024-02. The package contains 60 tablets and is manufactured by i3 Pharmaceuticals, LLC. The label includes dosage strength, storage conditions, and a barcode with additional product identification codes.*

FDA Label Image

Maraviroc-300mg (Maraviroc 300mg.jpg)

Label for Maraviroc Tablets 300 mg oral film-coated tablets, containing 60 tablets per container. The label states the drug is manufactured by i3 Pharmaceuticals, LLC, with storage instructions and dispensing warnings included. The NDC is 72319-025-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.